Regeneron Pharmaceuticals, Inc. (REGN) at a glance

Regeneron Pharmaceuticals, Inc. (REGN) is a large-cap Healthcare company. It trades at $784.14, with a P/E of 14.9, a 29.6% profit margin and revenue growth of 19%. It pays a 0.6% dividend yield. Vestovix scores it 67/100 overall. Its strongest dimension is Safety (94/100) and its weakest is Income (35/100). It is a relatively defensive holding with below-market volatility.

Price
$784.14
Market cap
$64.18B
P/E ratio
14.9
Dividend yield
0.60%
Beta
0.24
52-week range
$541.00 to $847.00
Vestovix Score67/ 100How this works
Value
90
Growth
46
Income
35
Safety
94
Momentum
72

Other Healthcare stocks

See all